In silico analysis of the transcriptional profile of chronic myeloid leukemia cells, in which CREB was knocked out demonstrated an upregulation of genes involved in tumor initiation and progression as well as in hypoxic signaling [49]. The gene discussed is CREB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.